ImpediMed Company Description

ImpediMed Limited, a medical technology company, develops, manufactures and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally.

The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-care body composition analysis; and HF-Dex analysis for point-of-care heart failure fluid assessment.

It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications.

ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.

ImpediMed Limited

Country	Australia
Founded	1999
Industry	Medical Devices
Sector	Healthcare
Employees	77
CEO	Parmjot Bains

Contact Details

Address: 5900 Pasteur Court Carlsbad, 92008 United States
Phone	760 585 2100
Website	impedimed.com

Stock Details

Ticker Symbol	IPD
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000IPD8
SIC Code	3845

Key Executives

Name	Position
Dr. Parmjot Bains M.D.	MD, Chief Executive Officer and Director
McGregor Grant BEc, C.A., FCIS, GAICD	Chief Financial Officer and Executive Director
Dennis Schlaht	Senior Vice President of Research & Development and Technology
Michael John Bassett	Vice President of Business Development and Investor Relations
Scott Long	Senior Vice President of US Sales, Key Accounts, and Renewals
Julie Kuhlken	Senior Director of Marketing
Ashley Munoz	Director of Human Resources
Dr. Steven Chen M.B.A., M.D.	Chief Medical Officer
Scott Savage	Chief Product Officer
Leanne Ralph AAICD, ACIS, BBus	Company Secretary